Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: Studies in vitro and in vivo

Biomaterials

Volumn 25, Issue 18, 2004, Pages 4287-4295

  Joosten, U ^a,b   Joist, A ^a   Frebel, T ^a   Brandt, B ^a   Diederichs, S ^a   Von Eiff, C ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b MarienHospital Osnabruck   (Germany)

Author keywords

Animal model; Antimicrobial; Bone cement; Infection; Osteoconduction

Indexed keywords

ANTIBIOTICS; BONE CEMENT; CALCIUM COMPOUNDS; HISTOLOGY; HYDROXYAPATITE; MICROBIOLOGY; PATHOLOGY; PROTEINS; RADIOLOGY;

CHRONIC OSTEOMYELITIS;

BIOMATERIALS;

ANTIBIOTIC AGENT; BIOMATERIAL; CALCIUM PHOSPHATE; DRUG CARRIER; GENTAMICIN; HYDROXYAPATITE; MORRHUATE SODIUM;

AGAR GEL DIFFUSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; COMPRESSION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL TEST; HEMATOLOGY; HISTOLOGY; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; INTERMETHOD COMPARISON; MICROBIOLOGY; MOLECULAR CLONING; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RABBIT; RADIOLOGY; STAPHYLOCOCCUS AUREUS; STRENGTH;

ANIMALIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 1642402002     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.10.083     Document Type: Article

References (48)

1. Härle A., Ritzerfeld W. The release of gentamycin into the wound secretions from polymethylmethacrylate beads. A study with reference to the animal experiment. Arch Orthop Trauma Surg. 95:1979;65-70.
2. Miclau T., Dahners L.E., Lindsey R.W. In vitro pharmacokinetics of antibiotic release from locally implantable materials. J Orthop Res. 11:1993;627-632.
3. Patzakis MJ, Mazur K, Wilkins J, Sherman R, Holtom P. Septopal beads and autogenous bone grafting for bone defects in patients with chronic osteomyelitis. Clin Orthop 1993;112-8.
4. Walther D. Histologische Untersuchungen nach Implantation von Gentamycin-PMMA-Kugeln bei chronischer Osteomyelitis. Unfallchirurgie. 3:1977;11-12.
5. Costantino P.D., Friedman C.D., Jones K., Chow L.C., Pelzer H.J., Sisson-GA S. Hydroxyapatite cement. I. Basic chemistry and histologic properties. Arch Otolaryngol Head Neck Surg. 117:1991;379-384.
6. Frankenburg EP, Bauer TW, Jiang M, Poser RD, Goldstein SA. Mechanical integrity of calcium phosphate cement in in-vivo metaphyseal models over time. 42nd Annual Meeting, Orthopedic Research Society, Atlanta, Georgia; 1996.
7. Frankenburg EP, Goldstein SA, Harris SA, Toomajin LR, Pellizzon GG, Bakker DA, Bauer TW. Evaluation of an in situ-setting calcium phosphate grout in an in vivo canine metaphyseal defect model. 40th Annual Meeting, Othopedic Research Society, New Orleans, Louisiana; 1994.
8. Friedman C.D., Costantino P.D., Jones K., Chow L.C., Pelzer H.J., Sisson-GA S. Hydroxyapatite cement. II. Obliteration and reconstruction of the cat frontal sinus. Arch Otolaryngol Head Neck Surg. 117:1991;385-389.
9. Shindo M.L., Costantino P.D., Friedman C.D., Chow L.C. Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg. 119:1993;185-190.
10. Constantz B.R., Ison I.C., Fulmer M.T. Skeletal repair by in situ formation of the mineral phase of bone. Science. 267:1995;1769-1799.
11. Patka P., Haarman H.J.T., Bakker F.C. Bottransplantaten en botvervangene materialien. Ned Tijdschr Geneeskd. 142:1998;893-896.
12. Sugawara A., Nishiyama M., Kusama K.et al. Histopathological reactions of calcium phosphate cement. Dent Mater J. 11:1992;11-16.
13. Takahashi A., Koshino T. Compressive and bone-bonding strength of hydroxyapatite thermal decomposition product implanted in the femur of rabbit as a bioactive ceramic bone cement. Biomaterials. 16:1995;937-943.
14. Kopylov P., Jonson K., Thorngren K.G., Aspenberg P. Injectable calcium phosphate in the treatmant of distal radius fractures. J Hand Surg [Br]. 21:1996;768-771.
15. Lykins C.L., Friedman C.D., Costantino P.D., Horioglu R. Hydroxyapatite cement in craniofacial skeletal reconstruction and its effects on the developing craniofacial skeleton. Arch Otolaryngol Head Neck Surg. 124:1998;153-159.
16. Joosten U., Joist A., Frebel T., Walter M., Langer M. The use of an in situ curing hydroxyapatite cement as an alternative to bone graft following removal of enchondroma of the hand. J Hand Surg [Br]. 25:2000;288-291.
17. Grove D., Randall W.A. Assay methods of antibiotics. A laboratory manual. 1955;Medical Encyclopedia, New York.
18. Norden C.W. Experimental osteomyelitis. A description of the model. J Infect Dis. 122:1970;410-418.
19. Norden C.W., Keleti E. Experimental osteomyelitis caused by pseudomonas aeruginosa. J Infect Dis. 141:1980;71-75.
20. Ichiyama S., Ohta M., Shimokata K., Kato N., Takeuchi J. Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 29:1991;2690-2695.
21. Böhm E., Könn G. Zur Morphologie der posttraumatischen Osteomyelitis. Unfallheilkunde. 79:1976;127-132.
22. Smeltzer M.S., Thomas J.R., Hickmon S.G.et al. Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res. 15:1997;414-421.
23. Norden C.W., Myerowitz R.L., Keleti E. Experimental osteomyelitis due to staphylococcus aureus or pseudomonas aeruginosa. A radiographic-pathological correlative analysis. Br J Exp Path. 61:1980;451-460.
24. Böhm E. Chronische posttraumatische osteomyelitis. Morphologie und pathogenese. Hefte Unfallheilk. 176:1986;1-109.
25. Garvin K.L., Miyano J.A., Robinson D., Giger D., Novak J., Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J Bone Jt Surg [Am]. 76:1994;1500-1506.
26. Gerhart T.N., Roux R.D., Hanff P.A., Horowitz G.L., Renshaw A.A., Hayes W.C. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats. J Orthop Res. 11:1993;250-255.
27. Laurencin C.T., Gerhart T., Witschger P.et al. Bioerodible polyanhydrides for antibiotic drug delivery. in vivo osteomyelitis treatment in a rat model system J Orthop Res. 11:1993;256-262.
28. Nijhof M.W., Dhert W.J.A., Timan P.B.J., Verbout A.J. Release of tobramycin from tobramycin-containing bone cement in bone and serum of rabbits. J Mater Sci. 8:1997;799-802.
29. Price J.S., Tencer A.F., Arm D.M., Bohach G.A. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 30:1996;281-286.
30. Wininger D.A., Fass R.J. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother. 40:1996;2675-2679.
31. Zhang X., Wyss U.P., Pichora D., Goosen M.F. Biodegradable controlled antibiotic release devices for osteomyelitis. optimization of release properties J Pharm Pharmacol. 46:1994;718-724.
32. Kawanabe K., Okada Y., Matsusue Y., Iida H., Nakamura T. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Jt Surg [Br]. 80:1998;527-530.
33. Winckler S., Overbeck J.P., Meffert R., Tormala P., Spiegel H.U. Resorbable ciprofloxacin/polyglycol acid carrier in the local therapy of chronic osteitis. Eur J Orthop Surg Traumatol. 5:1995;133-137.
34. Bloemers F.W., Patka P., Bakker F.C., Haarman H.J.T. Calciumfosfaatverbindingen als botvervangend material. Ned Tijdschr Traum. 2:1999;29-36.
35. Gosain A.K. Hydroxyapatite cement paste cranioplasty for the treatment of temporal hollowing after cranial vault remodeling in a growing child. J Craniofac Surg. 8:1997;506-511.
36. Ishihara K., Arai H., Nakabayashi N., Morita S., Furuya K. Adhesive bone cement containing hydroxyapatite particle as bone compatible filler. J Biomed Mater Res. 26:1992;937-945.
37. Kurashina K., Kurita H., Hirano M., Kotani A., Klein C.P., de-Groot K. In vivo study of calcium phosphate cements. implantation of an alpha-tricalcium phosphate/dicalcium phosphate dibasic/tetracalcium phosphate monoxide cement paste Biomaterials. 18:1997;539-543.
38. Kveton J.F., Friedman C.D., Piepmeier J.M., Costantino P.D. Reconstruction of suboccipital craniectomy defects with hydroxyapatite cement. a preliminary report Laryngoscope. 105:1995;156-159.
39. Knaack D., Aiolova M., Tofighi A.et al. α-BSM. a resorbable apatitic calcium phosphate bone substitute Bioceramics. 11:1998;357-361.
40. Aiolova M, Chakravarthy P, Majahad A, Lee DD. Evaluation of in vivo mechanical properties of a-BSM. 25th Annual Meeting, Society for Biomaterials, Minneapolis, 1999.
41. Wippermann BW, den Boer F, Schratt HE, Donow C, Wenz R, Haarman HJT, Tscherne H. The resorbable calcium phosphate cement alpha BSM in a sheep tibia segmental defect. 45th Annual Meeting, Orthopedic Research Society, Anaheim, California; 1999.
42. Norden C.W. Bone and joint infections. An update. Clin Infect Dis. 25:1997;1293-1294.
43. Proctor R.A., van Langevelde P., Kristjansson M., Maslow J.N., Arbeit R.D. Persistent and relapsing infections associated with small-colony-variants of Staphylococcus aureus. Clin Infect Dis. 20:1995;95-102.
44. von Eiff C., Bettin D., Proctor R.A.et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis. 25:1997;1250-1251.
45. Korkusuz F., Uchida A., Shinto Y., Araki N., Inoue K., Ono K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Jt Surg [Br]. 75:1993;111-114.
46. Costantino P.D., Friedman C.D., Jones K., Chow L.C., Sisson G.A. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg. 90:1992;174-185.
47. Frankenburg E.P., Goldstein G., Bauer T.W., Harris S.A., Bakker D.A. Biomechanical and histological properties of calcium phosphate cement. J Bone Jt Surg [Am]. 80:1998;1112-1124.
48. Müller-Mai C., Stupp S.I., Voigt C., Gross U. Nanoapatite and organo-apatite implants in bone. Histology and ultrastructure of the interface. J Biomed Mater Res. 29:1995;9-18.